Close Menu
  • FDA
  • Categories
    • Acute Lymphoblastic Leukemia
    • Acute Myelogenous Leukemia
    • Bone Metastases
    • Brain
    • Breast
    • Business Management
    • Cervical
    • Chronic Lymphocytic Leukemia
    • Chronic Myelogenous Leukemia
    • Colorectal
    • COVID-19
    • Gastrointestinal
    • General
    • Genitourinary
    • Head and Neck
    • Help
    • Hematologic Malignancies
    • Hodgkin Lymphoma
    • Imaging
    • Immunotherapy
    • Kidney
    • Liver
    • Lung
    • Lymphoma
    • Melanoma and Skin
    • Multiple Myeloma
    • Myeloproliferative Disease
    • News
    • Non-Hodgkin Lymphoma
    • Non-Small Cell Lung Cancer
    • Other
    • Ovarian
    • Pancreatic
    • Patient Resources
    • Pediatric
    • Prostate
    • Sarcoma
    • Sickle Cell
    • Small Cell Lung Cancer
    • Supportive Care
    • Testicular
    • Urology
    • Uterine
  • Conferences
    • AACR
    • ASBRS
    • ASCO
    • SABCS
    • ASH
    • MOASC
    • Upcoming Oncology Conferences
  • About
  • Contact
  • Advertise
Advertisement
X (Twitter) LinkedIn Facebook
X (Twitter) LinkedIn Facebook YouTube
OncologyTube
  • FDA
  • Categories
    • Acute Lymphoblastic Leukemia
    • Acute Myelogenous Leukemia
    • Bone Metastases
    • Brain
    • Breast
    • Business Management
    • Cervical
    • Chronic Lymphocytic Leukemia
    • Chronic Myelogenous Leukemia
    • Colorectal
    • COVID-19
    • Gastrointestinal
    • General
    • Genitourinary
    • Head and Neck
    • Help
    • Hematologic Malignancies
    • Hodgkin Lymphoma
    • Imaging
    • Immunotherapy
    • Kidney
    • Liver
    • Lung
    • Lymphoma
    • Melanoma and Skin
    • Multiple Myeloma
    • Myeloproliferative Disease
    • News
    • Non-Hodgkin Lymphoma
    • Non-Small Cell Lung Cancer
    • Other
    • Ovarian
    • Pancreatic
    • Patient Resources
    • Pediatric
    • Prostate
    • Sarcoma
    • Sickle Cell
    • Small Cell Lung Cancer
    • Supportive Care
    • Testicular
    • Urology
    • Uterine
  • Conferences
    • AACR
    • ASBRS
    • ASCO
    • SABCS
    • ASH
    • MOASC
    • Upcoming Oncology Conferences
  • About
  • Contact
  • Advertise
Subscribe
OncologyTube
Home » ASCO 2022 Lung Cancer Cancer Question & Answer
Lung

ASCO 2022 Lung Cancer Cancer Question & Answer

EditorBy EditorSeptember 19, 2022No Comments1 Min Read
Twitter LinkedIn Facebook Email
Share
Twitter LinkedIn Facebook Email

Question and Answer Session

Dr. Misako Nagasaka – ASCO [2022] Lung Cancer In-Depth Slides: MOASC Presentation

https://oncologytube.com/v/41320

Misako Nagasaka, MD  – About The Author, Credentials, and Affiliations

At the University of California in Irvine, Dr. Nagasaka is a board-certified thoracic oncologist who specializes in the detection and treatment of lung and thyroid cancer. He also treats patients with other types of thoracic cancer. In addition to that, early-phase clinical studies, medical ethics, and survivorship care for patients are some of her clinical interests. She attended the St. Marianna University School of Medicine in Kawasaki, Japan, where she was awarded both a doctoral degree and a medical degree. After completing her residency in internal medicine at Mount Sinai Beth Israel Hospital in New York City, she went on to finish a fellowship in hematology and oncology at the Karmanos Cancer Institute, which is part of the Wayne State University School of Medicine.

Lung Cancer Misako Nagasaka MOASC Question and Answer UC Irvine
Follow on X (Twitter) Follow on LinkedIn Follow on Facebook Follow on Google News
Share. Twitter LinkedIn Facebook Email

Related Posts

Cancer of Unknown Primary Diagnostics: Insights for Oncologists and Researchers

ASCO 4 Mins Read

Genitourinary Cancer [2025] Treatment Breakthroughs: ASCO GU 2025 Highlights Nataliya Mar, MD – MOASC

Genitourinary 6 Mins Read

ICI-Induced Myocarditis: When Chest Pain Isn’t What It Seems

General 3 Mins Read
Advertisement
Recent Posts
  • CHALLENGE Trial at ASCO 2025: Exercise Extends Life for Colon Cancer Survivors
  • ATOMIC Trial Results at ASCO 2025: Breakthrough for dMMR Stage III Colon Cancer
  • Cancer of Unknown Primary Diagnostics: Insights for Oncologists and Researchers
  • BRAFTOVI BREAKWATER Trial: Survival Results at ASCO 2025
  • AI in Oncology: Transforming Cancer Care at ASCO 2025
Connect With Us on Social
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
Donate
Advertise On OncologyTube.com
X (Twitter) LinkedIn Facebook YouTube
  • FDA
  • Categories
    • Acute Lymphoblastic Leukemia
    • Acute Myelogenous Leukemia
    • Bone Metastases
    • Brain
    • Breast
    • Business Management
    • Cervical
    • Chronic Lymphocytic Leukemia
    • Chronic Myelogenous Leukemia
    • Colorectal
    • COVID-19
    • Gastrointestinal
    • General
    • Genitourinary
    • Head and Neck
    • Help
    • Hematologic Malignancies
    • Hodgkin Lymphoma
    • Imaging
    • Immunotherapy
    • Kidney
    • Liver
    • Lung
    • Lymphoma
    • Melanoma and Skin
    • Multiple Myeloma
    • Myeloproliferative Disease
    • News
    • Non-Hodgkin Lymphoma
    • Non-Small Cell Lung Cancer
    • Other
    • Ovarian
    • Pancreatic
    • Patient Resources
    • Pediatric
    • Prostate
    • Sarcoma
    • Sickle Cell
    • Small Cell Lung Cancer
    • Supportive Care
    • Testicular
    • Urology
    • Uterine
  • Conferences
    • AACR
    • ASBRS
    • ASCO
    • SABCS
    • ASH
    • MOASC
    • Upcoming Oncology Conferences
  • About
  • Contact
  • Advertise
© 2025 Copyright Protected Medicus Networks, Inc. Privacy Policy

Type above and press Enter to search. Press Esc to cancel.